Dec 3, 2018 9:00 am EST Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study
Nov 28, 2018 4:05 pm EST Eyenovia Announces Publication of its PG21 Phase II Trial Results Demonstrating Robust IOP Lowering Effect and Patient Usability
Nov 26, 2018 5:26 pm EST Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study
Nov 13, 2018 7:30 am EST Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis
Nov 1, 2018 8:30 am EDT Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results
Oct 23, 2018 9:00 am EDT Eyenovia to Present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology 2018